Patents by Inventor Ken-ichi Sugita

Ken-ichi Sugita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMBINATION COMPRISING VITAMIN K
    Publication number: 20110028499
    Abstract: It is found that compounds having PPAR? agonistic activity induced abnormal blood coagulation or muscular disorder. A pharmaceutical combination comprising vitamin K and a compound having PPAR? agonistic activity can prevent the abnormal blood coagulation. A pharmaceutical composition comprising vitamin K can prevent muscular disorder.
    Type: Application
    Filed: September 30, 2010
    Publication date: February 3, 2011
    Applicant: SHIONOGI & CO., LTD.
    Inventors: Satoshi INOUE, Seiji SATO, Yoshimasa KYOKAWA, Ken-ichi SUGITA, Mikinori TORII
  • Pharmaceutical combination comprising vitamin k
    Publication number: 20090137614
    Abstract: It is found that compounds having PPAR? agonistic activity induced abnormal blood coagulation or muscular disorder. A pharmaceutical combination comprising vitamin K and a compound having PPAR? agonistic activity can prevent the abnormal blood coagulation. A pharmaceutical composition comprising vitamin K can prevent muscular disorder.
    Type: Application
    Filed: May 23, 2006
    Publication date: May 28, 2009
    Applicant: SHIONOGI & CO., LTD.
    Inventors: Satoshi Inoue, Seiji Sato, Yoshimasa Kyokawa, Ken-ichi Sugita, Mikinori Torii
  • Imidazole derivatives having anti-HIV activity
    Patent number: 5472965
    Abstract: A novel imidazole derivatives of formula I: ##STR1## wherein R.sup.1 is hydrogen, alkyl, halogen, or optionally substituted aryl; R.sup.2 is alkyl, optionally substituted aryl optionally substituted aralkyl, or optionally substituted hetero ring group; R.sup.3 is hydrogen, alkyl, optionally substituted aryl, optionally substituted aralkyl, or optionally substituted hydroxyalkyl; R.sup.4 is hydrogen, alkyl, halogen, acyl, optionally substituted hydroxyalkyl, optionally esterified or amidated carboxyl group, hydroxy group, aryl or arylthio; X is S, SO, SO.sub.2, CH.sub.2, or Se; n is an integer of 1 to 3, or a pharmaceutically acceptable salt thereof, said derivative having anti-HIV activity and being useful for the treatment of HIV infections.
    Type: Grant
    Filed: March 14, 1994
    Date of Patent: December 5, 1995
    Assignee: Shionogi & Co., Ltd.
    Inventors: Hirohiko Sugimoto, Masaru Ogata, Hiroshi Matsumoto, Ken-ichi Sugita, Akihiko Sato, Tamio Fujiwara
  • Imidazole derivatives having anti-HIV activity
    Patent number: 5326780
    Abstract: A novel imidazole derivatives of formula I: ##STR1## wherein R.sup.1 is hydrogen, alkyl, halogen, or optionally substituted aryl; R.sup.2 is alkyl, optionally substituted aryl optionally substituted aralkyl, or optionally substituted hetero ring group; R.sup.3 is hydrogen, alkyl, optionally substituted aryl, optionally substituted aralkyl, or optionally substituted hydroxyalkyl; R.sup.4 is hydrogen, alkyl, halogen, acyl, optionally substituted hydroxyalkyl, optionally esterified or amidated carboxyl group, hydroxy group, aryl or arylthio; X is S, SO, SO.sub.2, CH.sub.2, or Se; n is an integer of 1 to 3, or a pharmaceutically acceptable salt thereof, said derivative having anti-HIV activity and being useful for the treatment of HIV infections.
    Type: Grant
    Filed: January 12, 1993
    Date of Patent: July 5, 1994
    Assignee: Shionogi & Co., Ltd.
    Inventors: Hirohiko Sugimoto, Masaru Ogata, Hiroshi Matsumoto, Ken-ichi Sugita, Akihiko Sato, Tamio Fujiwara